申请人:Merck Sharp & Dohme Limited
公开号:US06579875B1
公开(公告)日:2003-06-17
1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing a fluoro-substituted phenyl ring at the 3-position and a heteroaryl-alkoxy moiety at the 6-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
在1,2,4-三唑并[4,3-b]吡嗪衍生物中,其在3位具有含氟取代的苯环,而在6位具有杂环烷氧基官能团,是选择性GABAA受体配体,特别是具有高亲和力的α2和/或α3亚基,对于治疗焦虑和抽搐非常有用。